Kangji Medical Holdings Limited

    Kangji Medical Holdings Limited

    HHKEX:9997
    9.20
    HKD
    0.00
    (0.00%)
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    Revenue per Share
    0.2
    0.28
    0.4
    0.54
    0.56
    0.65
    0.79
    0.86
    Basic EPS, GAAP
    0.09
    0.12
    0.16
    0.26
    0.37
    0.4
    0.43
    0.49
    Free Cash Flow per Basic Share
    0.1
    0.15
    0.25
    0.21
    0.33
    0.17
    0.29
    0.43
    Dividend per Share
    - -
    - -
    0.08
    0.22
    0.04
    0.15
    0.18
    1.4
    Book Value per Share
    - -
    - -
    - -
    - -
    0.5
    0.71
    0.94
    0.53
    Tangible Book Value per Share
    0.19
    0.37
    0.4
    3.08
    2.66
    2.7
    2.98
    2.24
    Basic Weighted Avg Shares
    1,252
    1,252
    1,252
    953
    1,224
    1,208
    1,170
    1,176
    Sales/Revenue/Turnover
    248
    354
    503
    511
    690
    786
    926
    1,009
    Operating Margin (%)
    66.74
    70.28
    74.14
    61.7
    65.58
    63.27
    54.1
    58.76
    Depreciation Expense
    6
    6
    7
    8
    12
    22
    33
    27
    Net Income, GAAP
    118
    147
    206
    250
    457
    479
    504
    581
    Effective Tax Rate (%)
    14.61
    14.31
    16.48
    16.42
    14.54
    18.11
    23.18
    16.58
    Profit Margin (%)
    47.56
    41.48
    41
    48.93
    66.18
    60.88
    54.43
    57.65
    Working Capital
    198
    414
    450
    2,855
    3,052
    2,970
    3,190
    1,803
    LT Debt
    - -
    - -
    - -
    4
    2
    42
    38
    - -
    Total Equity
    260
    484
    515
    2,937
    3,260
    3,719
    3,944
    2,629
    Return on Invested Capital (%)
    - -
    55.53
    60.03
    15.08
    12.37
    11.45
    9.76
    14.58
    Return on Capital (%)
    - -
    65.27
    47.54
    249.76
    148.21
    53.43
    41.44
    57.46
    Return on Common Equity (%)
    - -
    - -
    - -
    568,854.55
    150.38
    65.37
    51.49
    67.64

    Capital Structure

    CNY

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    CNY

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    93.5%
    -33.34%
    Free Cash Flow
    - -
    25.7%
    50.7%
    Net Income, GAAP
    - -
    25.84%
    15.36%
    Sales/Revenue/Turnover
    - -
    15.43%
    8.92%
    Total Cash Common Dividend
    - -
    200.8%
    661.42%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    926
    2024
    - -
    - -
    - -
    - -
    1,009
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    0.43
    2024
    - -
    - -
    - -
    - -
    0.49
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    0.18
    2024
    - -
    - -
    - -
    - -
    1.4
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business